Search

First Hybrid HOPE meeting in Bangkok, Thailand - a report

Sep 19 2022 Posted in Meeting reports Tagged HOPE, HOPE Asia, 2022, Hybrid, Bangkok

Highlights of Past EHA (HOPE) Asia 2022

September 2-3, 2022 – Bangkok, Thailand

Meeting chairs

A Almeida, President, European Hematology Association (EHA)
G Gaidano, Chair Global Outreach Committee, European Hematology Association (EHA)
P Rojnuckarin, President, Thai Society of Hematology (TSH)
S Hongeng, Vice President, Thai Society…

Patient organizations

EHA greatly values the collaboration with patient organizations in a growing number of areas, from joint advocacy and a strong presence at the EHA Annual Congress – with a prominent place for the EHA-Patient Joint Symposium on policy and regulatory…

Program

All session times are in Eastern European Time (EET).

Meeting program

Saturday, November 4*All times are in EET.

Highlights of Past EHA (HOPE) Asia 2020

EHA is returning to Sri Lanka for the 2nd edition of the Highlights of Past EHA (HOPE) Asia, organized with our hosting partner: the Sri Lanka College of Haematologists (SLCH).

Highlights from the SWG

SWG Session at EHA2023ELN-EHA SWG for CML: CML: modelling the futureChairJane Apperley (United Kingdom)

Topics and presenters
Identifying new targets for BCR::ABL1 inhibition: Oliver Hantschel (Germany). Dissecting phylogenetic trees in CML: Aleksandra Kamizela (United Kingdom).

Immunotherapy delivered by Blinatumomab improves survival in acute lymphoblastic leukaemia patients

Jun 10 2016 Posted in Press releases

Adult patients with acute lymphoblastic leukemia (ALL) can achieve disease control in 90% of cases with intense chemotherapy but only half of these responders will be cured.